Erythropoietin for Anemia in Jehovah's Witnesses
Authors: David Green, Ervin Handley
Journal: Annals of Internal Medicine (1990)

Letters1 November 1990Erythropoietin for Anemia in Jehovah's WitnessesDavid Green, MD, PhD, Ervin Handley, MDDavid Green, MD, PhDSearch for more papers by this author, Ervin Handley, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-113-9-720_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editors: Patients whose religious beliefs preclude acceptance of blood transfusions have been denied major surgery and usually have a protracted convalescence after blood loss. In three Jehovah's Witnesses, we observed that treatment with erythropoietin raised hemoglobin levels pre-operatively to levels that compensated for operative blood loss and enhanced recovery after major hemorrhage.A 41-year-old Jehovah's Witness was recommended for replacement of a porcine valve placed 11 years earlier. Her hemoglobin was 10.7 g/dL; serum iron, 34 µg%; total iron binding capacity, 224 µg%; and serum ferritin, 601 ng/mL. Treatment with erythropoietin (Ortho Biotech, Raritan, New Jersey), 150 U/kg...References1. WintrobeLeeBoggs MGD, eds. Clinical Hematology. Philadelphia: Lea and Febiger; 1981. Google Scholar2. DankoHuchHuch JRA. Epoetin alfa for treatment of postpartum anaemia [Letter]. Lancet. 1990;1:737-8. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: David Green, MD, PhD; Ervin Handley, MDAffiliations: Northwestern University Medical School Chicago, IL 60611 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byOptimising bloodless cardiovascular surgery for Jehovah’s Witnesses and beyondSuccessful Treatment of Severe Anemia Using Erythropoietin in a Jehovah Witness with Non-Hodgkin LymphomaSevere anemia after gastrointestinal hemorrhage in a Jehovah’s Witness: New treatment strategies*Use of Erythropoietin Following Emergent Surgery in a Jehovah'S WitnessUse of Erythropoietin in the Severely Anemic Jehovah's Witness Patient: Case Report and Review of the Literature5d Erythropoietin and iron in autologous haemotherapyAutologous blood transfusion: Preoperative blood collection and blood salvage techniquesThe use of erythropoietin in a patient having major oral and maxillofacial surgery and refusing blood transfusionEfficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: The importance of iron availability in optimizing responseUse of recombinant human erythropoietin to avoid blood transfusion in a Jehovah's Witness requiring hemispherectomyManagement of the Severely Anemic Patient Who Refuses Transfusion: Lessons Learned during the Care of a Jehovah's WitnessMarianne Culkin Mann, MD, John Votto, DO, Joseph Kambe, MD, Michael J. McNamee, MD 1 November 1990Volume 113, Issue 9Page: 720-721KeywordsAnemiaBloodBlood transfusionConvalescenceErythropoietinFerritinHemoglobinHemorrhageSurgeryTotal iron binding capacity ePublished: 1 December 2008 Issue Published: 1 November 1990 PDF downloadLoading ...